fb tracking

Product Recalls: February 14, 2024 – March 13, 2024

Health Letter, April 2024

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

For Class 1 recalls, there is a potential for serious injury or death.

For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.


clobazam tablets, 10 mg, 100-count bottle. Manufactured by: Micro Labs Limited. Lot #: ZOAG043.

hydralazine hydrochloride tablets, 10 mg, packaged in 100-count (10×10 blister cards). Manufactured for Heritage Pharmaceuticals, Inc. Lot #: T04680, exp. date: 6/2024.

mesalamine extended-release capsules, 500 mg, 120 capsules per bottle. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: MHD0606A or MHD0612A, exp. date: 04/30/2024; Lot #: MHD0613A, MHD0652A, MHD0657A, MHD0672A or MHD0673A, exp. date: 05/31/2024; Lot #: MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A or MHD0801A, exp. date: 06/30/2024; Lot #: MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A or MHD0901A, exp. date: 07/31/2024; Lot #: MHD1081A, MHD1082A or MHD1087A, exp. date: 09/30/2024.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.